AJMC July 26, 2024
Artificial intelligence (AI) models have potential to help clinicians assess risk in patients with hepatocellular carcinoma (HCC) to inform disease management, a new study found.
Artificial intelligence (AI)–driven predictive models could help personalize risk stratification for patients with hepatocellular carcinoma (HCC), helping clinicians identify modifiable risk factors and plan interventions to mitigate recurrence, according to a study published in the journal Liver International.1
In HCC that is not metastatic, surgical resection can be curative. Still, at least half of patients who undergo surgery with curative intent are estimated to experience recurrence within 5 years.2 In the new study, researchers aimed to incorporate metabolic risk factors into a model for risk stratification in HCC, as most models published to date have...
Today's Sponsors
Today's Sponsor